Showing results (391-400 of 582) with videos related to
Sort By:
Pageof 59
Toxicon : Official Journal of the International Society on Toxinology|February 6, 2013
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersMark Hallett, Alberto Albanese, Dirk Dressler, et al.Parkinsonism & Related Disorders|May 17, 2011
Essential tremor quantification during activities of daily livingDustin A Heldman, Joseph Jankovic, David E Vaillancourt, et al.Nature Reviews. Disease Primers|November 12, 2021
Essential tremorThomas Welton, Francisco Cardoso, Jonathan A Carr, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2013
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scaleGlenn T Stebbins, Christopher G Goetz, David J Burn, et al.Parkinsonism & Related Disorders|May 18, 2012
Amplitude fluctuations in essential tremorGiovanni Mostile, Robert Fekete, Joseph P Giuffrida, et al.Neurobiology of Disease|October 13, 2009
Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degenerationWen Zhu, Xuping Li, Wenjie Xie, et al.Neurosurgery|May 24, 2003
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomyManjit K Sanghera, Robert G Grossman, Christopher G Kalhorn, et al.Journal of Neurochemistry|September 3, 2003
Role of nitric oxide in rotenone-induced nigro-striatal injuryYi He, Syed Z Imam, Zaojun Dong, et al.Journal of Neurochemistry|May 21, 2015
Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cellsYa Feng, Te Liu, Su-Yan Dong, et al.Neuro-Signals|July 23, 2011
Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's diseaseYuncheng Wu, Xinqun Li, Julie Xiaohong Zhu, et al.Pageof 59